How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

Changing the Cancer World: An OncoDaily Session at SELAC 2026

Phase II LEAP-005 Results: Lenvatinib plus Pembrolizumab in Pretreated GI Cancers

PRECEDE Appoints Bryson Katona and Raymond Wadlow to its Executive Committee

Beyond the Guideline: What Uveal Melanoma Experts Say Still Needs Attention

Oncology News, Insights, Stories by OncoDaily

Empowering Oncologists: How Do We Apply Training, Research And Best Practices to Low Resource Settings
Dialogues

Empowering Oncologists: How Do We Apply Training, Research And Best Practices to Low Resource Settings

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition
OncoDaily

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

Myelo 2026
OncoDaily

Myelo 2026: Virtual Global Congress on Multiple Myeloma

Dean Crowe: Celebrating 20 Years – Rally Foundation Awards $7 Million in Childhood Cancer Research Grants

New Approaches to Strengthen HPV Vaccination and Prevent Cancer - European Cancer Organisation

UV Nail Lamps and Cancer Risk: Should You Worry? 2026

4 ADCs That Rewrote Breast Cancer Treatment History

Marty Makary: FDA Guidance Will Save Cell and Gene Therapy Developers Millions of Dollars and Years of Effort

Cosmetics And Cancer Risk: What Do We Really Know? 2026

Parker Institute and Cancer Vaccine Coalition Unite to Accelerate Cancer Vaccines

Voices
Shreyas Kalantri

Shreyas Kalantri: Pleased to Serve on ASCO Trainee and Early Career Advisory Group

Matt Sherer: UMC Health System Set to Open the TLC2 Foundation Cancer Center

Save the Date for the London Global Cancer Week 2026

Cathy Eng: Join Us for Early Onset Cancer Care Session at the AACR 2026 Global Affairs Session

Mary Nyangasi-Onyango:  WHO’s National Cancer Control Planning Course for Program Managers

Hedley Lewis: Stepping Down as CEO of CHOC Childhood Cancer Foundation SA

Darren Haywood: Our Paper on Cancer Planning Selected as Feature Article in Trends in Cancer

FDA Approvals
Tecartus

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

Aktis Advances Radiopharmaceutical Pipeline With AKY-2519 FDA Clearance

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

FDA Approves Combination Treatment of VENCLEXTA (venetoclax) and Acalabrutinib for Previously Untreated Patients With CLL

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

PANOVA-3 Leads to FDA Approval of Optune Pax in Locally Advanced Pancreatic Cancer

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Myelo 2026: Virtual Global Congress on Multiple Myeloma

OncoDaily

23 Apr
Multiple Myeloma

How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

OncoDaily

30 Apr
Head and Neck Cancers

Scalp Cooling for Prevention of Hair Loss in Pediatric ALL - Resonance

Resonance

08 May
Scalp Cooling

Treatment Strategy for a 4-Year-Old Boy with Newly Diagnosed MLL-AF4-Positive B-ALL

Resonance

24 Apr
Resonance

8th World Congress of the International Federation of Head and Neck Oncologic Societies (IFHNOS 2026)

International Federation of Head and Neck Oncologic Societies (IFHNOS)

26 Aug
IFHNOS

Immune-oncology
Beyond the Guideline: What Uveal Melanoma Experts Say Still Needs Attention

Beyond the Guideline: What Uveal Melanoma Experts Say Still Needs Attention

10 Must-Read Posts in Immuno-Oncology This Week

10 Clinical Trials on Immunotherapy in Triple Negative Breast Cancer

Microsatellite Instability (MSI)-The Biomarker That Changed Oncology Practice

Uveal Melanoma 2026: What the Latest ESMO–EURACAN Guideline Tells Us

Bispecific Antibodies vs CAR-T in Multiple Myeloma: Mechanisms, Clinical Outcomes, and Key Considerations

What Changed Immunotherapy in Bladder Cancer

Gastrointestinal-Oncology
LEAP-005 study

Phase II LEAP-005 Results: Lenvatinib plus Pembrolizumab in Pretreated GI Cancers

ESMO 2026 Guideline: Redefining the Management of Metastatic Colorectal Cancer

Immunotherapy in GI Cancers 2026: From Expansion to Precision

Phase 3 RASolute 302 Trial: Daraxonrasib Improves Overall Survival in Metastatic Pancreatic Cancer

10 Must-Read Posts In GI Oncology This Week

ctDNA Blood Tests in Colorectal Cancer Screening: High Specificity, Limited Detection of Precancerous Lesions

French Intergroup Guidelines 2026: Updates on Gastric Cancer Management

Breast-Oncology
ADCs

4 ADCs That Rewrote Breast Cancer Treatment History

PREDIX LumB: Palbociclib Did Not Beat Chemotherapy, But CDKPredX May Rescue the Strategy

DESTINY-Breast09: The Trial Changing the Future of HER2-Positive Breast Cancer

10 Breast Cancer Studies You Cannot Afford to Miss This Week

Neratinib With or Without Trastuzumab Shows Activity in HER2-Mutant Metastatic TNBC

The Throne Has Changed Hands: T-DXd Displaces T-DM1 in Post-Neoadjuvant HER2+ Breast Cancer

Breast-Conserving Surgery Plus Radiation Did Not Worsen Survival in Young BRCA1/2 Carriers, but Second Breast Events Remained Higher

Lung-Oncology
Can PD-L1 on Blood Immune Cells Predict Who Benefits From Durvalumab in ES-SCLC?

Can PD-L1 on Blood Immune Cells Predict Who Benefits From Durvalumab in ES-SCLC?

After 2 Years of Pembrolizumab in Advanced NSCLC, What Happens Next?

2026 ASCO Living Guideline for Stage IV NSCLC: The Updates Clinicians Should Not Miss

Two Phase 3 Trials That Changed Lung Cancer Treatment in 2025

TTF-1 Negativity in Lung Adenocarcinoma May Signal Broader Treatment Resistance

Serum CEA May Reflect Tumor Biology Across Molecular Subtypes in Metastatic NSCLC

KRAS G12C NSCLC: Promising Strategy as Cetuximab Boosts KRAS Inhibitor Response

OncoDaily TV
Empowering Oncologists: How Do We Apply Training, Research And Best Practices to Low Resource Settings

Empowering Oncologists: How Do We Apply Training, Research And Best Practices to Low Resource Settings

Precision at the Core: Advancing Nasopharyngeal Carcinoma Care with Proton Beam Therapy - Episode 1

Precision at the Core: Advancing Nasopharyngeal Carcinoma Care with Proton Beam Therapy – Episode 1

ACT for Children Initiative: Making a Durable Change

ACT for Children Initiative: Making a Durable Change

Bridging the Gap: Sustainable Cancer Care in Low and Middle Income Countries

Bridging the Gap: Sustainable Cancer Care in Low and Middle Income Countries

Ensuring equitable access to cancer care worldwide

Ensuring equitable access to cancer care worldwide: Pat Garcia-Gonzalez

How to Publish High-Impact Research in Top Journals

How to Publish High-Impact Research in Top Journals: Gustavo Monnerat

Empowering Oncologists

Empowering Oncologists: How Social Media Can Lead To Professional Collabortions And Advancement?

Dr. Amar Rewari

Challenges in Modern Cancer Care And How to Address Them: Dr. Amar Rewari

Fight Cancer, City of hope

This Could Change How We Fight Cancer Forever: Dr. Charles M. Balch

Ricardo Marques

The Moment People Ask for Help Is the Moment We Can’t Miss: Ricardo Marques

vraniCURE Nicole Beck Clifford

Building a Future Without Breast Cancer: vraniCURE & MBCure

Life is More Than Myeloma: Beyond Survival to Quality of Life

Life is More Than Myeloma: Beyond Survival to Quality of Life

Not To Miss
Breast Cancer

10 Breast Cancer Studies You Cannot Afford to Miss This Week

20 Posts Not To Miss From Texas Lung Cancer Conference 2026

Top 10 OncoGrants: Global Fellowships, Translational Funding & International Research Awards — April 2026

20 Posts Not To Miss From AYA Cancer Awareness Week 2026

10 Posts From Lung Oncology You Can’t Miss This Week

15 Posts Not To Miss From World Health Day - April 7

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

OncoGrants
AACR Immuno‑Oncology Research Fellowship

AACR Immuno‑Oncology Research Fellowship

Damon Runyon–Dale F. Frey Award for Breakthrough Scientists

Damon Runyon–Dale F. Frey Award for Breakthrough Scientists

Damon Runyon Fellowship Award

Damon Runyon Fellowship Award

LCRF Leading Edge Research Grant

LCRF Leading Edge Research Grant

American Cancer Society Clinician Scientist Development Grant

American Cancer Society Clinician Scientist Development Grant

American Cancer Society Postdoctoral Fellowship

American Cancer Society Postdoctoral Fellowship

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Follicular lymphoma (FL)

Follicular Lymphoma (FL): From Evolving Biology to Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

CancerWorld

Oncologists
Hagar El-Ghazawy

Hagar El-Ghazawy

Oncologists Location Cairo, Egypt
Antonella Cammarota

Antonella Cammarota

Oncologists Location Milan, Italy
Garik Sagoyan

Garik Sagoyan

Oncologists Location , Italy
Robert E. Reiter

Robert E. Reiter

Oncologists Location Los Angeles, USA
Denis Leonardo Fontes Jardim

Denis Leonardo Fontes Jardim

Oncologists Location São Paulo, Brazil
Tezer Kutluk

M. Tezer Kutluk

Oncologists Location Ankara, Türkiye
Eduard-Alexandru Bonci

Eduard-Alexandru Bonci

Oncologists Location Lisbon, Portugal
Ruzanna Papyan

Ruzanna Papyan

Oncologists Location Yerevan, Armenia

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
ROSELLA Trial

The ROSELLA trial: Relacorilant + Nab-Paclitaxel Improves Survival in Platinum-Resistant Ovarian Cancer

Bi-Specific T cell

Bi-Specific T Cell Engagers in Cancer Therapy: Mechanisms, Advances, and Clinical Impact

KRAS G12V

KRAS G12V–Mutated NSCLC: Smoking-Driven Biology and Immunotherapy Sensitivity

KEYNOTE-158

KEYNOTE-158 Trial: Pembrolizumab Monotherapy in MSI-H/dMMR Recurrent Gliomas:

PRINCE Trial

PRINCE Trial: Lu-PSMA-617 Plus Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

NCCN 2026

NCCN Annual Conference 2026: The Evolving Treatment Landscape for Gastric, Esophageal, and EGJ Cancers

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0310-6131

Prevalence and Associated Factors of Cholelithiasis in Pediatric Sickle Cell Disease Patients at Qatif Health Network, Saudi Arabia
Original Research

Precision Oncology

10.69690/ODMJ-002-0226-7267

Unlocking Precision Medicine in Multiple Myeloma: Venetoclax and Novel Targeted Therapies
Review

Oncology Nursing

10.69690/ODMJ-002-0204-6423

Extracorporeal membrane oxygenation in the management of oncologic critical illness
Review

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts